Addressing the root cause of metabolic disorders.
Our treatment
How Physiologic Insulin Resensitization™ Works
MSII leverages an innovative and patented approach, Physiologic Insulin Resensitization™, where insulin is administered as a hormone rather than a conventional drug. This groundbreaking technique directly addresses the root cause of Diabetes—metabolic failure. By mimicking normal physiology, this modality aims to reduce insulin resistance, enabling blood sugar to enter cells more efficiently for energy conversion.
The use of insulin as a hormone communicator aligns with the body's natural maintenance of optimized metabolism, distinguishing our approach from the traditional use of insulin as a symptom-suppressing drug. This physiologically identical method contributes to the reduction of insulin resistance, fostering a more natural and effective response.
Cellular Revitalization for Metabolic Repair
By enhancing cellular energy, our protocol is designed to initiate the repair and regeneration of the body's cells. Initially focusing on peripheral areas, repeated treatment sessions progress to cellular restoration in organs. This comprehensive approach aids the body in naturally returning to a more normal physiologic state. Consequently, the treatment not only stabilizes but, in many instances, has demonstrated the potential to reverse complications associated with diabetes and other metabolic disorders.
Managing Chronic Metabolic Impairment
It's important to note that metabolic impairment is a chronic condition. While our treatments offer significant improvements, discontinuing therapy may result in diminishing benefits over time. The goal is to manage symptoms effectively, acknowledging that this is not a cure but a transformative approach to enhance overall metabolic health.
Typical Treatment Plan
Every individual's level of insulin resistance and carbohydrate metabolism efficiency is distinct. To commence the journey towards personalized care, we initiate with a consultation to determine medical necessity and establish a customized plan directed by our physicians.
The personalized care plan generally consists of an "Induction Phase" involving two infusions per week, gradually reducing to one per week over approximately 90 days. This is followed by a "Maintenance Phase," where the focus is on achieving a harmonious balance between optimized metabolism and insulin sensitivity, while striving to extend the intervals between treatments.
Our approach has proven effective for Type 2 Diabetic, Prediabetic, and Nondiabetic patients, who often experience a reduction in infusion duration from 3 hours to 2 hours. They successfully maintain optimized metabolism and insulin sensitivity, achieving intervals of four to six weeks between treatments.
